Published in Lab Law Weekly, January 26th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Biogen Idec.
Report 1: Biogen Idec (BIIB) announced that scientists have discovered that a receptor in the central nervous system (CNS) may have a specific function in the neurons that degenerate during the progression of Parkinson disease.
This research, discovered by a team of Biogen Idec-led scientists, is the first to suggest that inhibiting the Nogo-66 receptor (NgR1) may provide therapeutic benefit in the treatment of Parkinson's disease.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly